Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like Invacare Proposes $100 Million Raise June 8, 2017 Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi January 31, 2018 Meet the Little-Known Biotech and Its CEO Going After Alzheimer's Hard January 11, 2018
